BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11306049)

  • 1. Three different stable human breast adenocarcinoma sublines that overexpress ALDH3A1 and certain other enzymes, apparently as a consequence of constitutively upregulated gene transcription mediated by transactivated EpREs (electrophile responsive elements) present in the 5'-upstream regions of these genes.
    Sreerama L; Sládek NE
    Chem Biol Interact; 2001 Jan; 130-132(1-3):247-60. PubMed ID: 11306049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient induction of increased aldehyde dehydrogenase 3A1 levels in cultured human breast (adeno)carcinoma cell lines via 5'-upstream xenobiotic, and electrophile, responsive elements is, respectively, estrogen receptor-dependent and -independent.
    Sládek NE
    Chem Biol Interact; 2003 Feb; 143-144():63-74. PubMed ID: 12604190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.
    Sládek NE
    Curr Pharm Des; 1999 Aug; 5(8):607-25. PubMed ID: 10469894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
    Sreerama L; Sladek NE
    Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse cytosolic class 3 aldehyde dehydrogenase (Aldh3a1): gene structure and regulation of constitutive and dioxin-inducible expression.
    Vasiliou V; Reuter SF; Williams S; Puga A; Nebert DW
    Pharmacogenetics; 1999 Oct; 9(5):569-80. PubMed ID: 10591537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
    Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
    Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multienzyme-mediated stable and transient multidrug resistance and collateral sensitivity induced by xenobiotics.
    Rekha GK; Sladek NE
    Cancer Chemother Pharmacol; 1997; 40(3):215-24. PubMed ID: 9219504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
    Sládek NE; Kollander R; Sreerama L; Kiang DT
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens.
    Sreerama L; Sládek NE
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):255-62. PubMed ID: 11320670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
    Sreerama L; Sladek NE
    Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive and 3-methylcholanthrene-induced rat ALDH3A1 expression is mediated by multiple xenobiotic response elements.
    Reisdorph R; Lindahl R
    Drug Metab Dispos; 2007 Mar; 35(3):386-93. PubMed ID: 17151192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
    Montano MM; Jaiswal AK; Katzenellenbogen BS
    J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase.
    Rekha GK; Sreerama L; Sladek NE
    Biochem Pharmacol; 1994 Nov; 48(10):1943-52. PubMed ID: 7986206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance.
    Sreerama L; Rekha GK; Sladek NE
    Biochem Pharmacol; 1995 Mar; 49(5):669-75. PubMed ID: 7887982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and transport of oxazaphosphorines and the clinical implications.
    Zhang J; Tian Q; Yung Chan S; Chuen Li S; Zhou S; Duan W; Zhu YZ
    Drug Metab Rev; 2005; 37(4):611-703. PubMed ID: 16393888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N; Chen J; Yoshida A
    Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin [correction of Tryphostin] AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements.
    Dieter MZ; Freshwater SL; Solis WA; Nebert DW; Dalton TP
    Biochem Pharmacol; 2001 Jan; 61(2):215-25. PubMed ID: 11163336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldehyde dehydrogenases and cell proliferation.
    Muzio G; Maggiora M; Paiuzzi E; Oraldi M; Canuto RA
    Free Radic Biol Med; 2012 Feb; 52(4):735-46. PubMed ID: 22206977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide.
    Maki PA; Sladek NE
    Biochem Pharmacol; 1993 Jan; 45(1):231-9. PubMed ID: 8424816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of steroid sulphatase expression and activity in breast cancer.
    Newman SP; Purohit A; Ghilchik MW; Potter BV; Reed MJ
    J Steroid Biochem Mol Biol; 2000 Dec; 75(4-5):259-64. PubMed ID: 11282280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.